Rock Springs Capital Management LP Beam Therapeutics Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$19.53 - $34.09 $2 Million - $3.48 Million	-102,203 Reduced 40.52%	150,020 $2.93 Million
Q4 2024 Feb 14, 2025	BUY	$21.55 - $30.35 $49,565 - $69,805	2,300 Added 0.92%	252,223 $6.26 Million
Q2 2024 Aug 14, 2024	BUY	$21.22 - $32.66 $2.17 Million - $3.34 Million	102,413 Added 69.43%	249,923 $5.86 Million
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $846,436 - $1.63 Million	36,080 Added 32.38%	147,510 $4.87 Million
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $3.33 Million - $6.95 Million	111,430 New	111,430 $4.31 Million

249

95M

888K

549K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.